AstraZeneca UK Ltd. v. Orchid Chemicals & Pharmaceuticals Ltd.

Delhi High Court | Decided: 13 April 2012 I.A. No. 18464/2011 in CS (OS) No. 1421/2005 Bench: Justice Manmohan Singh Citation: 2012 PTC DEL 50 380 | 2012 SCC Online Del 2092 | 2012 CTC IP 3 6

Background

AstraZeneca UK Ltd. (plaintiff) was the registered proprietor of the trade mark MERONEM, used for pharmaceutical products – specifically, a carbapenem antibiotic used in hospital settings. Orchid Chemicals & Pharmaceuticals Ltd. (defendant) was an Indian pharmaceutical manufacturer that had adopted the trade mark MEROMER for similar pharmaceutical products. AstraZeneca filed a suit for trade mark infringement (CS (OS) No. 1421/2005) before the Delhi High Court in 2005, claiming that MEROMER was deceptively similar to and infringed its registered mark MERONEM.

The litigation had a long and layered procedural history. In 2005, AstraZeneca filed rectification proceedings before the IPAB against the defendant’s mark MEROMER, without first obtaining the leave of the Court. The defendant challenged this in I.A. No. 8561/2005 under Order XXXIX Rule 4 CPC. A Single Judge of the Delhi High Court, by an order dated 16 May 2006, held that a party seeking to file rectification proceedings after the institution of a suit must first obtain the prima facie satisfaction of the Court about the invalidity of the opposing mark, before proceeding to file such rectification petition. This ruling was confirmed by the Division Bench of the Delhi High Court in FAO(OS) Nos. 445-46/2006. The defendant did not challenge these findings, file cross-objections or bring to the Court’s attention the fact that it had itself filed rectification proceedings against AstraZeneca’s mark MERONEM before the IPAB (bearing No. 94.TM/Del/2005) during the same period – i.e., in 2005 – without prior leave of the Court.

Years later, in 2011, the defendant filed the present application (I.A. No. 18464/2011) seeking a stay of the infringement suit under Section 124 of the Trade Marks Act, 1999 read with Section 151 CPC, on the ground that its rectification proceedings against MERONEM were pending before the IPAB. The defendant also pointed out that AstraZeneca itself had challenged the defendant’s mark MEROMER before the IPAB. AstraZeneca opposed the application on grounds of maintainability, time bar, res judicata and constructive res judicata.

Issues for Determination

The Court was called upon to determine:

1. Whether the infringement suit should be stayed under Section 124 of the Trade Marks Act, 1999, pending the disposal of rectification proceedings initiated by the defendant before the IPAB against the plaintiffs’ mark MERONEM.
2. Whether prior leave of the Court is a condition precedent for filing rectification proceedings so as to attract the stay mechanism under Section 124 of the Act – and whether the defendant, having accepted this position in prior proceedings, could now resile from it.
3. Whether the defendant’s present application for stay was barred by the doctrines of res judicata, constructive res judicata and approbate-reprobate (estoppel by conduct).
4. Whether the factual circumstance that the plaintiff’s mark MERONEM was registered in the name of Zeneca Limited (a non-party) absolved the defendant of the requirement to obtain leave of the Court before filing rectification proceedings.

Key Holdings of the Court

1. The Court held that under Section 124 of the Trade Marks Act, 1999, where rectification proceedings are not already pending at the time of the institution of the suit, a party wishing to file such proceedings after the suit has been instituted must first obtain the prima facie satisfaction of the Court about the invalidity of the opposing trade mark before approaching the IPAB. This is a mandatory procedural condition, not a mere technicality. A party that bypasses this requirement cannot invoke Section 124 to obtain a stay of the infringement suit.
2. The Court held that the defendant was bound by the findings of the Single Judge (16 May 2006) and the Division Bench (in FAO(OS) Nos. 445-46/2006), both of which had clearly established that leave of the Court was a condition precedent for filing rectification proceedings post-suit. The defendant had accepted these findings without challenge, cross-objection or appeal and could not now be permitted to take a contrary position.
3. The Court held that the defendant’s present application was barred by the principles of res judicata and constructive res judicata. The question of whether leave of the Court was required under Section 124 had been conclusively decided in the earlier proceedings and the defendant, having accepted those findings, was precluded from re-agitating the same issue at a later stage of the same proceedings.
4. The Court applied the doctrine of approbate-reprobate – a facet of estoppel – holding that the defendant, having taken advantage of and accepted the findings of the Division Bench when they operated in its favour, could not now seek to resile from those findings when they operated to its detriment. A litigant cannot blow hot and cold – taking one position when it is convenient and an inconsistent position when circumstances change.
5. The Court rejected the defendant’s argument that the mark MERONEM being registered in the name of Zeneca Limited (a non-party) absolved it of the leave requirement. The relevant question was the time of filing of the rectification proceedings in 2005 – and at that time, AstraZeneca was relying on the MERONEM registration in the suit. The factual circumstances were on all fours with those that had been considered and decided by the Single Judge and Division Bench. No differential treatment could be accorded to the defendant’s rectification.
6. The application was dismissed with costs of Rs. 5,000/-.

Statutory Provisions Involved

Section 124, Trade Marks Act, 1999 – The central provision. It deals with stay of infringement suits where the validity of a trade mark registration is questioned. It provides two scenarios: (i) Section 124(1)(b)(i) – where rectification proceedings are already pending before the Registrar or IPAB at the time of the suit, the court shall stay the suit pending final disposal of those proceedings; and (ii) Section 124(1)(b)(ii) – where no such proceedings are pending, the court must be satisfied prima facie that the plea of invalidity is tenable, frame an issue and grant time of three months to the concerned party to apply to the IPAB for rectification. Only after such an application is made and accepted is the suit to be stayed. Section 124(5) preserves the court’s power to deal with interlocutory applications even during a stay.

Section 111, Trade and Merchandise Marks Act, 1958 – The predecessor provision to Section 124 of the 1999 Act, whose identical framework was relied upon and interpreted in Kedar Nath v. Monga Perfumery & Flour Mills (AIR 1974 Delhi 12), one of the key precedents applied in this case.

Section 151, Code of Civil Procedure, 1908 – Inherent powers of the court, invoked alongside Section 124 in the stay application.

Order XXXIX Rules 1, 2 and 4, Code of Civil Procedure, 1908 – The provisions under which the earlier interlocutory applications had been filed and decided by the Single Judge in 2006.

Reasoning of the Court

The Court’s reasoning was grounded in the procedural history of the litigation and the doctrines of res judicata, estoppel and abuse of process, rather than a fresh examination of the substantive merits of Section 124.

The Court first mapped the two scenarios contemplated by Section 124. Where rectification proceedings are already pending, the stay is automatic upon their being brought to the court’s attention. Where no such proceedings are pending, the statute requires the court’s active gatekeeping function – the party must demonstrate prima facie invalidity to the court’s satisfaction before being allowed to go to the IPAB. This gatekeeping function exists precisely to prevent parties from using the filing of a rectification petition as a strategic device to indefinitely stay infringement proceedings, absent a genuinely tenable invalidity challenge.

The Court then identified the critical factual circumstance: the defendant’s rectification against MERONEM was filed in 2005, after the suit was instituted and without first obtaining the prima facie satisfaction of the Court. The defendant had, moreover, been present in proceedings where exactly this procedural question was decided – both before the Single Judge and the Division Bench – and had accepted those findings without challenge. Having acquiesced in those findings and built its own litigation conduct on them, the defendant could not suddenly reverse course and advance a contrary legal position six years later.

The Court invoked Barkat Ali v. Badrinarain (2008) 4 SCC 615 to establish that res judicata applies not only across separate proceedings but also at successive stages of the same proceedings, precluding a court from revisiting a question it has already decided. It applied Kok Hoong v. Leong Cheong Kweng Mines Ltd. (1964 AC 993) for the proposition that a litigant who has elected a course of action before the court – and procured orders on the basis of that election – cannot be permitted to abandon that course and start afresh. And it relied on Dwijendra Narain Roy v. Joges Chandra De (AIR 1924 Cal 600) for the classic formulation of the approbate-reprobate doctrine: a party cannot be permitted to blow hot and cold, taking inconsistent positions in successive stages of the same or related proceedings.

The Court also rejected the defendant’s argument about the non-party status of the registered proprietor (Zeneca Limited) as a basis for distinguishing the previous findings, reasoning that the operative question was always the timing of the rectification filing and the absence of prior court leave – both of which were identical in the defendant’s case as in the plaintiff’s case that had been decided by the Division Bench.

Doctrinal Significance

This judgment, though decided on an interlocutory application, makes several meaningful contributions to the intersection of trade mark law and procedural doctrine.

It clarifies the mandatory nature of the prima facie satisfaction requirement under Section 124(1)(b)(ii). Where rectification proceedings are not pre-existing, the court’s gatekeeping role is not optional – a party that bypasses the court and goes directly to the IPAB cannot subsequently invoke those self-initiated proceedings to seek a stay under Section 124. The court’s prima facie satisfaction is a jurisdictional precondition, not a procedural formality.

It firmly establishes that res judicata applies within the same suit at successive stages. Drawing on the Supreme Court’s articulation in Barkat Ali v. Badrinarain, the Court applies this principle to prevent a party from re-agitating a procedural question that had been conclusively decided in the same proceeding by both a Single Judge and a Division Bench.

It applies the approbate-reprobate doctrine robustly in IP litigation. The judgment is an important example of a court refusing to permit a litigant to take contradictory positions at different stages of the same dispute. This is particularly significant in IP matters, where parties often engage in complex, multi-forum litigation spanning years and may be tempted to shift positions as circumstances evolve.

It draws a clear analogy between Section 111 of the Trade and Merchandise Marks Act, 1958 and Section 124 of the Trade Marks Act, 1999, confirming that the same procedural principles apply under both enactments and that precedents under the earlier Act remain relevant to the interpretation of the successor provision.

It provides a practical cautionary note about strategic use of rectification proceedings. The judgment signals that the court will closely scrutinize attempts to invoke Section 124 where rectification proceedings were filed without court leave, particularly where the applicant has previously accepted the legal necessity of that leave in the same litigation.

Articles Case Laws Copyright Article Copyright case laws Patent Article patent case laws Trademark Article Trademark case laws